Related Experiment Video
Updated: May 16, 2026

09:46
Reconstituting Cytoarchitecture and Function of Human Epithelial Tissues on an Open-Top Organ-Chip
Published on: February 17, 2023
CHIP clinics: a practical overview of structure and function.
Shyam A Patel1, Abhishek A Mangaonkar2
1Department of Medicine, Division of Hematology/Oncology, UMass CHIP Clinic, UMass Chan Medical School, Worcester, MA, USA. shyam.patel@umassmed.edu.
Blood Cancer Journal
|May 14, 2026
Summary
Clonal hematopoiesis of indeterminate potential (CHIP) clinics are emerging globally. This study proposes a working model for establishing effective CHIP clinics to advance translational science and patient care.
Area of Science:
- Hematology
- Pre-malignant conditions
- Translational science
Background:
- Clonal hematopoiesis of indeterminate potential (CHIP) is a pre-malignant condition.
- Existing CHIP clinics aim to standardize management.
- Translational research is limited by nascent therapeutic concepts and follow-up data.
Purpose of the Study:
- To explore the structure and function of current CHIP clinics.
- To propose a working model for future CHIP clinics in academic and community settings.
- To identify critical elements for operationalizing CHIP clinic workflows.
Main Methods:
- Review of existing CHIP clinic structures and functions.
- Development of a proposed working model for CHIP clinic operationalization.
- Discussion of key components including patient identification, personnel recruitment, and workflow design.
Main Results:
- CHIP clinics offer clinical utility in preventive hematology and risk assessment.
- They facilitate clinical trial enrollment, research registries, and tissue biorepositories.
- Multidisciplinary teams and community outreach are crucial for effective CHIP clinics.
Conclusions:
- Establishing standardized CHIP clinics is vital for advancing translational science.
- These clinics can improve patient outcomes through enhanced risk assessment and research opportunities.
- Future multi-center collaboration holds promise for developing new CHIP therapeutics.

